A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 749
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CS
Long Form : cardiogenic shock
No. Year Title Co-occurring Abbreviation
2021 A case report of cobalt cardiomyopathy leading to electric storm and cardiogenic shock: the importance of the orthopaedic background in patients with heart failure of unknown aetiology. ---
2021 A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre. pVAD
2021 Admission Serum Ionized and Total Calcium as New Predictors of Mortality in Patients with Cardiogenic Shock. iCa, MIMIC-III, tCa
2021 Association Between Anion Gap and Mortality in Critically Ill Patients with Cardiogenic Shock. AG
2021 Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study. ACS, LDL-C
2021 Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry. CI, HR, PVD, VIS
2021 Association Between Timing of Extracorporeal Membrane Oxygenation and Clinical Outcomes in Refractory Cardiogenic Shock. ECMO
2021 Association of Lymphocyte to Monocyte Ratio and Risk of in-Hospital Mortality in Patients with Cardiogenic Shock: A Propensity Score Matching Study. HR, IPTW, LMR, MIMIC-IV, PSM, ROC, SOFA
2021 Awake venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock. MV, PS, VA-ECMO
10  2021 Axial flow ventricular assist devices in cardiogenic shock complicating acute myocardial infarction. MCS
11  2021 Biventricular Impella (Bi-Pella) in Refractory Cardiogenic Shock: The First Case from the Middle East. AMI-CS, Bi-Pella, BiVF, CPO, CVP, PAPi
12  2021 Blood Urea Nitrogen and In-Hospital Mortality in Critically Ill Patients with Cardiogenic Shock: Analysis of the MIMIC-III Database. BUN, CI, OR
13  2021 Body mass index and all-cause mortality in patients with cardiogenic shock: A systematic review and meta-analysis. BMI, CI
14  2021 Budget Impact Associated with the Introduction of the Impella 5.0® Mechanical Circulatory Support Device for Cardiogenic Shock in France. MCS, VA-ECMO
15  2021 Cardiogenic shock and machine learning: A systematic review on prediction through clinical decision support softwares. AUC, ML, ROCs
16  2021 Cardiogenic shock teams and centres: a contemporary review of multidisciplinary care for cardiogenic shock. MCS
17  2021 Characteristics and Outcome of Acute Heart Failure in Infective Endocarditis: Focus on Cardiogenic Shock. AHF
18  2021 Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry. OR
19  2021 Comparison of Mechanical Support with Impella or Extracorporeal Life Support in Post-Cardiac Arrest Cardiogenic Shock: A Propensity Scoring Matching Analysis. AMI, ECLS, LVEF, OHCA
20  2021 Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support. AMI, APACHE II, AUC, IABP, OHCA, SAPS II, SAVE, SOFA
21  2021 Comparison of Outcomes Among Patients With Cardiogenic Shock Admitted on Weekends Versus Weekdays. ---
22  2021 Comparison of Outcomes of Coronary Artery Disease Treated by Percutaneous Coronary Intervention in 3 Different Age Groups (<45, 46-65, and >65 Years). ACS, CAD, OHCA, PCI, STEMI
23  2021 Crossing the chasm: caution for use of angiotensin receptor-neprilysin inhibition in patients with cardiogenic shock- a case report. AKI, ARNI, Cr, HFrEF
24  2021 Data-driven point-of-care risk model in patients with acute myocardial infarction and cardiogenic shock. AMI-CS, MCS, PCI, ROC-AUC
25  2021 Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction. AUC, CI, CIC, DCA, LASSO, LightGBM, LR, STEMI, XGBoost
26  2021 Device-related complications after Impella mechanical circulatory support implantation: an IMP-IT observational multicentre registry substudy. DRCs, HR-PCI
27  2021 Effects of mechanical circulatory support devices in patients with acute myocardial infarction undergoing stent implantation: a systematic review and meta-analysis of randomised controlled trials. AMI, IABP, MCS, pVADs, RCTs, RRs
28  2021 Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials. AMI, MCS, RCTs
29  2021 Epidemiological profile, management and outcomes of patients with acute coronary syndrome: Single centre experience from a tertiary care hospital in North India. AKI, CHB, RBBB
30  2021 Epidemiology of cardiogenic shock and cardiac arrest complicating non-ST-segment elevation myocardial infarction: 18-year US study. CA, NSTEMI, ORs
31  2021 Epinephrine administration in venoarterial extracorporeal membrane oxygenation patients is associated with mortality: a retrospective cohort study. ECMO, VA
32  2021 Escalation and de-escalation of mechanical circulatory support in cardiogenic shock. LV, MCS, RV
33  2021 Estimation of Stressed Blood Volume in Patients With Cardiogenic Shock From Acute Myocardial Infarction and Decompensated Heart Failure. AMI-CS, eSBV, HF-CS, SBV
34  2021 Factors Associated with the Prognosis of Patients with Acute Myocardial Infarction and Cardiogenic Shock. AMI, CI, IABP, OR, PCI, TIMI
35  2021 Fifteen-Year Trends in Incidence of Cardiogenic Shock Hospitalization and In-Hospital Mortality in the United States. ---
36  2021 Five-year risk of heart failure and death following myocardial infarction with cardiogenic shock: a nationwide cohort study. CI, HR, MI
37  2021 Fluid Resuscitation In Cardiogenic Shock: An Assessment Of Responsiveness And Outcome. ICU, NSTEMI, PLR
38  2021 Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support - a case report. COVID-19, EMB, MCS, SARS-CoV-2
39  2021 Hospitalization-related economic impact of patients with cardiogenic shock in a high-complexity reference centre. LYG
40  2021 Impact of Age on Outcomes in Patients With Cardiogenic Shock. CSWG, SCAI
41  2021 Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial. BB
42  2021 Impact of hospital transfer to hubs on outcomes of cardiogenic shock in the real world. CI, OR
43  2021 Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular Failure. ---
44  2021 Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis. aOR, MCS
45  2021 IMPELLA® or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock. LV, MCS, VA-ECMO
46  2021 In-Hospital Utilization and Outcomes of Palliative Care Consultation in Patients With Advanced Heart Failure Complicated by Cardiogenic Shock Requiring Mechanical Circulatory Support. HF, MCS, PC
47  2021 Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity. AKI, CICU, SCAI
48  2021 Increasing stroke events in patients with ST elevation myocardial infraction and cardiogenic shock: A cause for concern. MCS
49  2021 Influence of age and shock severity on short-term survival in patients with cardiogenic shock. SCAI
50  2021 Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity. ACS, IABP, IPTW, SCAI
51  2021 Intra-aortic balloon pump on in-hospital outcomes of cardiogenic shock: findings from a nationwide registry, China. CI, IABP, OR, PCI
52  2021 Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association. MCS
53  2021 Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock. ---
54  2021 Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip®-procedure: a new option for critically ill patients. MCS, MR
55  2021 Left Ventricle Architecture and Valvular Integrity Following Microaxial Mechanical Support: A Two-Year Follow-Up Study. LV
56  2021 Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. AMI, IABP, MACCE, pMCS
57  2021 Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction. AMI, CI, HF, HR, OR
58  2021 Mechanical circulatory support in acute myocardial infarction and cardiogenic shock: Challenges and importance of randomized control trials. AMI, MCS
59  2021 Mortality in patients with cardiogenic shock supported with VA ECMO: A systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients. AMI, CA, HF, PE, VA-ECMO
60  2021 Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial Infarction. LVEF, NGAL, STEMI
61  2021 Outcome and Predictors for Mortality in Patients with Cardiogenic Shock: A Dutch Nationwide Registry-Based Study of 75,407 Patients with Acute Coronary Syndrome Treated by PCI. ACS, DM, MI, NHR, OHCA, PCI
62  2021 Outcome of patients with non-ischaemic cardiogenic shock supported by percutaneous left ventricular assist device. AMI, pVADs, VA-ECMO
63  2021 Outcomes of cardiogenic shock with autoimmune rheumatological disorders. AID, NIS
64  2021 Palliative Care Services in Patients Admitted With Cardiogenic Shock in the United States: Frequency and Predictors of 30-Day Readmission. PCS
65  2021 Pathophysiology of cardiogenic shock. ---
66  2021 Percutaneous mitral valve repair assisted by a catheter-based circulatory support device in a heart transplant patient. MR, tempMCS
67  2021 Perhexiline treatment improves toxic effects of β-adrenergic receptor stimulation in experimental peripartum cardiomyopathy. beta-AR, ISO, PP, PPCM
68  2021 Peripheral venoarterial extracorporeal membrane oxygenation for periprocedural Cardiogenic shock during interventional cardiology. CCL, PCI, pVA-ECMO
69  2021 Phenotyping Cardiogenic Shock. DRR
70  2021 Predicting survival in patients with acute decompensated heart failure complicated by cardiogenic shock. ADHF
71  2021 Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock. CI, CLO-PCI, CR, MI, MV-PCI, PCI, rSS
72  2021 Predictors of Clinical Outcome After Early Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction. STEMI, VA-ECMO
73  2021 Predictors of Hemodynamic Response to Intra-Aortic Balloon Pump Therapy in Patients With Acute Decompensated Heart Failure and Cardiogenic Shock. CI, CO, HF, IABP, mPAP, OR, SVR
74  2021 Predictors of Hospital Mortality in Patients with Acute Coronary Syndrome Complicated by Cardiogenic Shock. AAR, ACS, CI, GFR, LV, OR, PCI, TTECG
75  2021 Predictors of Mortality in Patients Treated with Veno-Arterial ECMO for Cardiogenic Shock Complicating Acute Myocardial Infarction: a Systematic Review and Meta-Analysis. AMI, VA-ECMO
76  2021 Prognostic value of neutrophil-lymphocyte ratio in cardiogenic shock complicating acute myocardial infarction: A cohort study. AMI, MACE, NLR
77  2021 Quality of Life Following Urgent LVAD Implantation for ECMO Therapy in Cardiogenic Shock: A Long-Term Follow-Up. CPR, EQ-5D-5L, LVAD, MCS, VA-ECMO
78  2021 Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock. aOR, CI, MCS, STEMI
79  2021 Radial approach reduces mortality in patients with ST-segment elevation myocardial infarction and cardiogenic shock. FA, PCI, PSM, RA, STEMI
80  2021 Randomized clinical trials of patients with acute myocardial infarction-related cardiogenic shock: a systematic review of used cardiogenic shock definitions and outcomes. AMI, PCI, RCT
81  2021 Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock. AS, BAV, GI, HF, NRD, TAVI
82  2021 Regional differences in presentation characteristics, use of treatments and outcome of patients with cardiogenic shock: Results from multicenter, international registry. MCS
83  2021 Revascularization Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock: Results from the Portuguese Registry on Acute Coronary Syndromes. MI, MVD, ProACS, STEMI
84  2021 Right Atrial Pressure Is Associated With Outcomes in Patient With Cardiogenic Shock Receiving Acute Mechanical Circulatory Support. AMCS, RAP
85  2021 Sex differences in patients with cardiogenic shock. CI, OR
86  2021 Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock: results from the CardShock Study. sTREM-1, TREM-1
87  2021 ST-Segment Elevation Acute Myocardial Infarction Complicated by Cardiogenic Shock: Early Predictors of Very Long-Term Mortality. AUC, STEMI
88  2021 Survival Following Edge-to-Edge Transcatheter Mitral Valve Repair in Patients With Cardiogenic Shock: A Nationwide Analysis. ---
89  2021 Temporary mechanical circulatory support devices: updates from recent studies. ECMO, MCS
90  2021 The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial. aRR, CI, MAP
91  2021 The mechanical support of cardiogenic shock. COVID-19, MCS
92  2021 The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction. AMI, CI, CLIP
93  2021 Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization. AMI, PCI, PSW
94  2021 Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock. LA, LAFAB, MCS
95  2021 Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study). MR, MVARC, PMVR
96  2021 Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry). AMI, MR, PMVR
97  2021 Use of Post-Acute Care Services and Readmissions After Acute Myocardial Infarction Complicated by Cardiac Arrest and Cardiogenic Shock. AMI, CA, HR
98  2021 VA-ECMO With IABP is Associated With Better Outcome Than VA-ECMO Alone in the Treatment of Cardiogenic Shock in ST-Elevation Myocardial Infarction. IABP, LM, SAVE, STEMI, VA-ECMO
99  2021 Vasoactive pharmacologic therapy in cardiogenic shock: a critical review. AMI, BP, CO, NE, NOSI, RCTs
100  2021 [The Value of Using SCAI Cardiogenic Shock Stages in Predicting Mortality in CICU Patients]. AUC, CICU, GRACE, SCAI